Cargando…
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
BACKGROUND: Previous studies have shown that Trimetazidine (TMZ) improves vascular endothelial function and reduces the inflammatory process progression. However, limited data have been available regarding its effects on myocardial fibrosis following ischemia and causing left ventricular dysfunction...
Autores principales: | El-khodary, Noha M., Ghoneim, Asser I., El-tayaar, Ahmed A., El-touny, Eman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516770/ https://www.ncbi.nlm.nih.gov/pubmed/35538296 http://dx.doi.org/10.1007/s10557-022-07340-0 |
Ejemplares similares
-
Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018) -
Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice
por: Zhang, Jinmeng, et al.
Publicado: (2020) -
Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy – Six months follow-up result
por: Momen, A., et al.
Publicado: (2016) -
Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015)